ezlopitant has been researched along with Disease Models, Animal in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bartlett, SE; Bito-Onon, JJ; Holgate, J; Nielsen, CK; Simms, JA; Steensland, P | 1 |
Adams, C; Bilsky, EJ; Cormier, J; Dunbar, C; Mercer, H; Negus, SS; Stevenson, GW | 1 |
2 other study(ies) available for ezlopitant and Disease Models, Animal
Article | Year |
---|---|
The neurokinin 1 receptor antagonist, ezlopitant, reduces appetitive responding for sucrose and ethanol.
Topics: Alcohol Drinking; Animals; Benzylamines; Bridged Bicyclo Compounds, Heterocyclic; Disease Models, Animal; Eating; Ethanol; Humans; Hyperphagia; Male; Mice; Mice, Inbred C57BL; Neurokinin-1 Receptor Antagonists; Rats; Rats, Long-Evans; Receptors, Neurokinin-1; Self Administration; Sucrose; Water | 2010 |
Targeting pain-depressed behaviors in preclinical assays of pain and analgesia: drug effects on acetic acid-depressed locomotor activity in ICR mice.
Topics: Acetic Acid; Analgesia; Analgesics; Animals; Behavior, Animal; Benzene Derivatives; Caffeine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Haloperidol; Male; Mice; Mice, Inbred ICR; Morphine; Motor Activity; Pain; Pain Measurement | 2009 |